(S1 (S (S (NP (NP (JJ Small) (JJ molecule-mediated) (NN disruption)) (PP (IN of) (NP (NP (JJ Wnt-dependent) (NN signaling)) (PP (IN in) (NP (NP (NN tissue) (NN regeneration)) (CC and) (NP (NN cancer)))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ pervasive) (NN influence)) (PP (IN of) (NP (JJ secreted) (NN Wnt) (NN signaling) (NNS proteins))) (PP (IN in) (NP (NP (NN tissue) (NN homeostasis)) (CC and) (NP (NN tumorigenesis))))) (VP (VBZ has) (VP (VBN galvanized) (S (VP (VBZ efforts) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ small) (NNS molecules)) (SBAR (WHNP (WDT that)) (S (VP (VBP target) (NP (JJ Wnt-mediated) (JJ cellular) (NNS responses)))))))))))))) (. .)))
(S1 (S (S (PP (IN By) (S (VP (VBG screening) (NP (DT a) (JJ diverse) (JJ synthetic) (JJ chemical) (NN library))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN discovered) (NP (NP (CD two) (JJ new) (NNS classes)) (PP (IN of) (NP (NP (JJ small) (NNS molecules)) (SBAR (WHNP (WDT that)) (S (VP (VBP disrupt) (NP (NN Wnt) (NN pathway) (NNS responses))))))))))) (: ;) (S (SBAR (IN whereas) (S (NP (CD one) (NN class)) (VP (VBZ inhibits) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NN Porcupine)) (, ,) (NP (NP (DT a) (JJ membrane-bound) (NN acyltransferase)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ essential) (PP (TO to) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN Wnt) (NNS proteins)))))))))))))))) (, ,) (NP (DT the) (JJ other)) (VP (VBZ abrogates) (NP (NP (NN destruction)) (PP (IN of) (NP (NN Axin) (NNS proteins))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (NP (NP (NNS suppressors)) (PP (IN of) (NP (NN Wnt/beta-catenin) (NN pathway) (NN activity)))))))))) (. .)))
(S1 (S (PP (IN With) (NP (DT these) (JJ small) (NNS molecules))) (, ,) (NP (PRP we)) (VP (VBP establish) (NP (NP (DT a) (JJ chemical) (JJ genetic) (NN approach)) (PP (IN for) (S (VP (VBG studying) (NP (NP (NN Wnt) (NN pathway) (NNS responses)) (CC and) (NP (NN stem) (NN cell) (NN function))) (PP (IN in) (NP (JJ adult) (NN tissue)))))))) (. .)))
(S1 (S (S (S (NP (PRP We)) (VP (VBP achieve) (NP (NP (ADJP (ADJP (JJ transient)) (, ,) (ADJP (JJ reversible))) (NN suppression)) (PP (IN of) (NP (NP (NN Wnt/beta-catenin) (NN pathway)) (NN response)))) (ADVP (FW in) (FW vivo)))) (, ,) (CC and) (S (NP (PRP we)) (VP (VBP establish) (NP (NP (DT a) (JJ mechanism-based) (NN approach)) (S (VP (TO to) (VP (VB target) (NP (JJ cancerous) (NN cell) (NN growth))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN signal) (NN transduction) (NNS mechanisms)) (VP (VBN shown) (ADVP (RB here)) (S (VP (TO to) (VP (VB be) (ADJP (RB chemically) (JJ tractable))))))) (ADVP (RB additionally)) (VP (VP (VBP contribute) (PP (TO to) (NP (JJ Wnt-independent) (NN signal) (NN transduction) (NNS pathways)))) (CC and) (VP (ADVP (RB thus)) (VP (MD could) (VP (VB be) (ADVP (RB broadly)) (VP (VBN exploited) (PP (IN for) (NP (NP (JJ chemical) (NNS genetics)) (CC and) (NP (JJ therapeutic) (NNS goals)))))))))) (. .)))
